MedTrace Logo

Efficacy of Respiratory Physiotherapy on Severe ICU-admitted COVID-19 Patients.

NCT05067907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 244

Last updated 2022-07-19

No results posted yet for this study

Summary

COVID-19 is an infectious disease caused by SARS-CoV2 virus. COVID-19 patients can develop a severe disease that can lead to hypoxic respiratory failure and acute respiratory distress syndrome (ARDS). Severe patients can require access to intensive care unit (ICU). Early rehabilitation is known to be effective in critically ill patients and in ARDS.

Early rehabilitation is known to be effective in critically ill subjects. The role of physiotherapy in severe COVID-19 patients is still unclear and few guidelines have been proposed so far. Aim of this study is to assess efficacy of early rehabilitation for severe ICU-admitted COVID-19 patients as compared to a group that did not received physiotherapy treatment in ICU.

Conditions

  • COVID-19 Acute Respiratory Distress Syndrome

Interventions

PROCEDURE

Early physiotherapy

Respiratory physiotherapy included: 1. early and functional mobilization: passive and active mobilization, muscle strengthening, improving independence in activities of daily living (ADL), sitting out of bed, standing, walking; 2. patient positioning to achieve better ventilation/perfusion ratio and gas exchange; 3. airway clearance; 4. aerosol administration; 5. invasive mechanical ventilation weaning; 6. use of non-invasive mechanical ventilation (NIMV) and continuous positive airway pressure (CPAP); 7. tracheostomy management and weaning; 8. swallowing assessment; 9. management of oxygen delivery; 10. lung expansion; 11. patient assessment and functional scale administration.

Sponsors & Collaborators

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    lead OTHER

Principal Investigators

  • Emilia Privitera, MSC · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-10-30
Completion
2021-12-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05067907 on ClinicalTrials.gov